An existing drug already used to treat other conditions could potentially be used to treat patients who have newly been diagnosed with type 1 diabetes . The drug, Rituxan, is currently used to treat rheumatoid arthritis and Hodgkin’s Lymphoma.
The potential type 1 diabetes drug is produced by Genentech – a unit of Roche Holding AG and Biogen Idec Inc. The diabetes drug could help patients to produce their own insulin, even if the pancreatic beta cells have already been attacked and destroyed.
The drug is currently under trial for diabetic use. Dr. Mark Pescovitz, the lead researcher of the study, was reported as saying: "What this study does is open the door to a whole new way to approaching type 1 diabetes."
New type 1 diabetes drug
Thu, 26 Nov 2009
Recommended links
Diabetes based financial servicesDiabetes competitions
Diabetes forum
Diabetes donate
Diabetes mylifestyle
Diabetes.co.uk Alert ID wristband
The Diet Plate for People with Diabetes
Diabetes pensions and annuities
Diabetes drug warning has doctors on alert
Label change for type 2 diabetes drug
Diabetes prevention using diet, not drugs
Diabetes drug better for weight loss
Diabetes drug may have pancreatitis risk
Denial over diabetes drug link
Heart risk not alleviated by diabetes drugs
Obesity increases diabetes drug bill
Med diet could delay diabetes drugs
Diabetes drug prescriptions must stop, study says
Stop prescribing diabetes drug, scientists say
New diabetes drug same price
Dementia drug risk amongst people with diabetes
Iron binding drug could help diabetes neuropathy
Diabetes drug cleared of cancer risk
Canada reviews diabetes drug
Diabetes drug review causes share climb
Sanofi maintain diabetes drug no riskier than insulin
Diabetes drug cleared for European market
Drug association encourages use of diabetes drug
Diabetes drug requires more research, FDA rule
Takeda diabetes drug setback
Diabetes drug reaching stage three trials
Study confirms how diabetes drugs can increase heart risk
New diabetes drug promising results
Join us